Abstract:We have developed a cation ion nanoparticulate sulfonated polystyrene solution (NSPS) to target and chelate tumor microenvironment hydroxyapatite (TME‐HAP) releasing phosphate and hydroxyl ions in the TME and subsequently inducing acute localized alkalosis. Chelation of TME‐HAP with NSPS resulted in the inhibition of tumor cell metabolism and proliferation leading to tumor cell apoptosis in mouse models. There are no other known injectable compounds that can break up TME‐HAP in vivo making NSPS a one‐of‐a‐kind and first in a class of novel cancer therapeutics. Background It has been shown that tumor microenvironment (TME) hydroxyapatite (HAP) is typically associated with many malignancies and plays a role in tumor progression and growth. Additionally, acidosis in the TME has been reported to play a key role in selecting for a more aggressive tumor phenotype, drug resistance and desensitization to immunotherapy for many types of cancers. TME‐HAP is an attractive target for tumor detection and treatment development since HAP is generally absent from normal soft tissue. We provide strong evidence that dissolution of hydroxyapatite (HAP) within the tumor microenvironment (TME‐HAP) using a novel therapeutic can be used to kill cancer cells both in vitro and in vivo with minimal adverse effects. Methods We developed an injectable cation exchange nano particulate sulfonated polystyrene solution (NSPS) that we engineered to dissolve TME‐HAP, inducing localized acute alkalosis and inhibition of tumor growth and glucose metabolism. This was evaluated in cell culture using 4T1, MDA‐MB‐231 triple negative breast cancer cells, MCF10 normal breast cells, and H292 lung cancer cells, and in vivo using orthotopic mouse models of cancer that contained detectable microenvironment HAP including breast (MMTV‐Neu, 4T1, and MDA‐MB‐231), prostate (PC3) and colon (HCA7) cancer using 18F‐NaF for HAP and 18F‐FDG for glucose metabolism with PET imaging. On the other hand, H292 lung tumor cells that lacked detectable microenvironment HAP and MCF10a normal breast cells that do not produce HAP served as negative controls. Tumor microenvironment pH levels following injection of NSPS were evaluated via Chemical Exchange Saturation (CEST) MRI and via ex vivo methods. Results Within 24 h of adding the small concentration of 1X of NSPS (~7 μM), we observed significant tumor cell death (~ 10%, p

Monodispersed Calcium Carbonate Nanoparticles Modulate Local Ph and Inhibit Tumor Growth in Vivo

CaCO3 Nanoparticles Ph-Sensitively Induce Blood Coagulation As a Potential Strategy for Starving Tumor Therapy.

Nano CaCO3 “lysosomal Bombs” Enhance Chemotherapy Drug Efficacy Via Rebalancing Tumor Intracellular Ph

Acetazolamide-Loaded pH-Responsive Nanoparticles Alleviating Tumor Acidosis to Enhance Chemotherapy Effects.

Acidity-Responsive Fe-PDA@CaCO3 Nanoparticles for Photothermal-Enhanced Calcium-Overload- and Reactive-Oxygen-Species-Mediated Tumor Therapy

Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift

CaCO3 Nanoparticles As an Ultra-Sensitive Tumor-Ph-responsive Nanoplatform Enabling Real-Time Drug Release Monitoring and Cancer Combination Therapy

Regulation of Ion Homeostasis for Enhanced Tumor Radio‐Immunotherapy

Tumor Microenvironment Modulating CaCO3‐based Colloidosomal Microreactors Can Generally Reinforce Cancer Immunotherapy

CaCO3-complexed pH-responsive nanoparticles encapsulating mitoxantrone and celastrol enhance tumor chemoimmunotherapy

CaCO 3 -complexed pH-responsive nanoparticles encapsulating mitoxantrone and celastrol enhance tumor chemoimmunotherapy

Tumor-Targeted Disruption of Lactate Transport with Reactivity-Reversible Nanocatalysts to Amplify Oxidative Damage

Advancements in Ph-Responsive Nanocarriers: Enhancing Drug Delivery for Tumor Therapy

Peritumoral Scaffold Neutralizes Tumor Ph for Chemotherapy Sensitization and Metastasis Inhibition.

pH-responsive nanoparticles for cancer drug delivery

Calcium Peroxide-Based Nanosystem with Cancer Microenvironment-Activated Capabilities for Imaging Guided Combination Therapy via Mitochondrial Ca 2+ Overload and Chemotherapy

Metal-polyphenol-network coated CaCO3 as pH-responsive nanocarriers to enable effective intratumoral penetration and reversal of multidrug resistance for augmented cancer treatments

Biocompatible superparamagnetic sub-micron vaterite particles for thermo-chemotherapy: From controlled design to in vitro anticancer synergism

Cascade Catalytic Nanoparticles Selectively Alkalize Cancerous Lysosomes to Suppress Cancer Progression And Metastasis

Tumor microenvironment-tailored nanoplatform for companion diagnostic applications of precise cancer therapy

Synthesis of CaCO<sub>3</sub>-Based Nanomedicine for Enhanced Sonodynamic Therapy via Amplification of Tumor Oxidative Stress